Intervention

conventional

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial BlockerNCT02133235 · 2014-05-01

COMPLETED

Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound ManagementNCT01814267 · 2013-03-01

COMPLETED

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateNCT01444820 · 2012-01-01

ACTIVE_NOT_RECRUITING

Common conditions

Diabetes1 Diabetic Foot Ulcer1 Neoplasms, Pulmonary1 Prostate Cancer1 Thoracic Diseases1

Leading sponsors

National Taiwan University Hospital 1 Sir Mortimer B. Davis - Jewish General Hospital 1 University Hospital, Grenoble 1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE32

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.